Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+12.56%
+0.83%
+4.59%
-5.10%
LH
Laboratory Corporati
$254.78
Chart
$247.05 (+3.13%)
$221.4 (+15.08%)
$257.2 (-0.94%)
$209.55 (+21.58%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+12.56%
+0.83%
+4.59%
-5.10%
LH
Laboratory Corporati
Current Price
$254.78
Strong Sell
Login to view Laboratory Corporati (LH) recommendation from the last 90 days from financial news and social media.
Chart
$247.05 (+3.13%)
$221.4 (+15.08%)
$257.2 (-0.94%)
$209.55 (+21.58%)
LH Latest Analysis
Northstar Calgary Facility Produces First Liquid Asphalt - Releases Construction & Commissioning Video #6. ) (OTCQB:) (".Northstar". or the ".Company".) is extremely pleased to announce that its inaugural asphalt shingle reprocessing facility in Empower Calgary Facility". or the ".Facility".) has produced its first liquid asphalt. All the major processing units at the Facility have now been commissioned demonstrating an important derisking of the Company'.s technology and
Today
Labcorp Declares Quarterly Dividend. (NYSE:) a global leader of innovative and comprehensive laboratory services announced today that its Board of Directors has declared a cash dividend of ...
Today
Hong Kong: Chinas IPO Pipeline And Crypto Lab.
Tue Jul 8, 2025
BAE Systems to develop AI-powered software to improve battlefield medical care for warfighters. BROOMFIELD Colo. July 3 2025 /PRNewswire/ -- The Air Force Research Laboratory (AFRL) has selected BAE Systems (LON: BA) to continue development and support deployment of the Battlefield Assisted Trauma Distributed Operations Kit (BATDOK®) through the new Force Optimization through...
Thu Jul 3, 2025
Spartanburg Regional Healthcare System (SRHS) Selects AccessDx Laboratory as Pharmacogenomics (PGx) Program Partner. Collaboration empowers clinicians with personalized insights and furthers health equity in precision medicine SPARTANBURG S.C. and HOUSTON July 2 2025 /PRNewswire/ -- Spartanburg Regional Healthcare System (SRHS) has selected AccessDx Laboratory as its partner to power a comprehensive...
Wed Jul 2, 2025
Laboratory Information Management System Market worth US$5.19 billion by 2030 with 12.5% CAGR | MarketsandMarkets™.. Delray Beach FL June 27 2025 (GLOBE NEWSWIRE) -- The global laboratory information management system market valued at US$2.54 billion in 2024 stood at US$2.88 billion in 2025 and is projected to advance at a resilient CAGR of 12.5% from 2025 to 2030 culminating in a forecasted valuation of US$5.19 billion by the end of the period. The adoption of cloud-based LIMS is driven by the
Fri Jun 27, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Hover over the category for more information
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings